 |
|
|
| |
Innovations and implementation of long-acting antiretroviral therapy
|
| |
| |
At IAS this symposium on Long-Acting CAB/RPV discussed why some PWH are interested in LA ART and the access, availability & challenges in the USA & in LIMC. For PWH who have problems with adherence LA CAB/RPV has been studied with promising results with more study ongoing in non-adherent PLWH in the ACTG. there were 3 slide talks in this session.
Advances in LA-ART: New drugs and new methods of delivery
( B. CRABTREE )
Implementation in populations with suboptimal adherence
( A. RANA )
|
| |
|
|
|
|
|
